Sex as a major determinant of pro-longevity drug efficacy: a review of two decades of the NIA Interventions Testing Program
Nisi Jiang(The University of Texas Southwestern Medical Center), James F. Nelson(The University of Texas at San Antonio Health Science Center), Ziying Xu(Lanzhou University of Technology), Randy Strong(The University of Texas at San Antonio Health Science Center), Jonathan Gelfond(The University of Texas at San Antonio Health Science Center), Shangang Zhao(The University of Texas at San Antonio Health Science Center)
Cited by 2
Related Papers
Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging
|Physiological Genomics|2003|733
Rapamycin‐mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction
|Aging Cell|2013|629
Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability
|EBioMedicine|2023|275
High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance
|Nature Communications|2021|269
Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer
|European Urology|2018|224